"MIT scientists have worked out how to encase potent vaccines in nanoparticle shells -- creating nanovaccine delivery systems, a trick that could have serious implications in fighting difficult-to-kill viruses like HIV," Fast Company reports (Eaton, 2/22). "The new particles, described in the Feb. 20 issue of Nature Materials, consist of concentric fatty spheres that can carry synthetic versions of proteins normally produced by viruses," according to an MIT press release. Darrell Irvine, author of the paper and an associate professor of materials science and engineering and biological engineering at MIT, said the "synthetic particles elicit a strong immune response -- comparable to that produced by live virus vaccines -- but should be much safer" (2/22). The technology has been "tested successfully in mice, and worked to convert large numbers of T-cells to act as vaccine," Fast Company adds (2/22).
Back to other news for February 2011
This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy